Lansoprazole and Kidney small - a phase IV clinical study of FDA data

Summary:

Kidney small is reported as a side effect among people who take Lansoprazole (lansoprazole), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Prevacid, and have Gallbladder disease.

The phase IV clinical study analyzes which people have Kidney small when taking Lansoprazole. It is created by eHealthMe based on reports of 128,069 people who have side effects when taking Lansoprazole from the FDA, and is updated regularly.

What is Lansoprazole?

Lansoprazole has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 129,663 Lansoprazole users. Check the latest studies of Lansoprazole.

What is Kidney small?

Kidney small is found to be associated with 147 drugs and 192 conditions by eHealthMe. Check the latest studies of Kidney small.

On Jul, 18, 2026

128,069 people reported to have side effects when taking Lansoprazole.
Among them, 34 people (0.03%) have Kidney small.

Among these 34 people:

How long have people been on Lansoprazole when they have Kidney small? *

What is the gender of people who have Kidney small when taking Lansoprazole? *

female: 48.39 %
male: 51.61 %

What is the age of people who have Kidney small when taking Lansoprazole? *

What are other drugs people take besides Lansoprazole? *

Prevacid: 32 people, 94.12%
Pantoprazole: 20 people, 58.82%
Prevacid 24 Hr: 6 people, 17.65%
Protonix: 3 people, 8.82%
Ticlopidine Hydrochloride: 1 person, 2.94%
Simvastatin: 1 person, 2.94%
Quinine Sulfate: 1 person, 2.94%
Prednisolone: 1 person, 2.94%
Neoral: 1 person, 2.94%
Mycophenolate Mofetil: 1 person, 2.94%

What are other side effects people have besides Kidney small? *

Chronic Kidney Disease: 32 people, 94.12%
Acute Kidney Failure: 26 people, 76.47%
Hypertensive Nephropathy (hypertensive renal disease): 21 people, 61.76%
Nephropathy (damage to or disease of a kidney): 21 people, 61.76%
Renal Injury (kidney injury): 20 people, 58.82%
Renal Impairment (severely reduced kidney function): 17 people, 50.00%
Kidney Stones: 13 people, 38.24%
Blood Creatinine Increased: 12 people, 35.29%
Renal Cyst (kidney cyst): 12 people, 35.29%
Renal Atrophy (wasting of kidney): 12 people, 35.29%

What are the existing conditions these people have? *

Indigestion: 7 people, 20.59%
Gallbladder Disease: 7 people, 20.59%
Gastric Disorder (disease of stomach): 2 people, 5.88%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Lansoprazole and have Kidney small?

- Check whether Kidney small is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lansoprazole:

Lansoprazole (129,663 reports)

Kidney small treatments and more:

Kidney small (599 reports)

Browse all side effects of Lansoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Kidney small:

Kidney small (147 drugs)

Browse all the conditions that are associated with Kidney small:

Kidney small (192 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lansoprazole (the active ingredients of Lansoprazole) and Lansoprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.